Rishab Kumar

Rishab’s practice encompasses a range of strategic business transactions, with a focus on M&A, joint ventures, minority investments, and related corporate and securities law matters. He has advised on M&A transactions representing an aggregate value of more than $100 billion.

Rishab also advises high-growth technology companies and venture capital and private equity/growth equity funds on private financings and investment transactions.

Rishab has practiced in India, London, New York, Hong Kong and Silicon Valley and has extensive cross-border experience advising clients on foreign investment transactions in India and Southeast Asia.

Rishab was named to the Silicon Valley Business Journal’s and the Economic Times’ (India) 40 Under 40 lists for 2025.

Rishab’s representative transactions include advising:

Representative buy-side transactions

• NVIDIA (NASDAQ: NVDA) in several M&A transactions, strategic investments, joint ventures and data center transactions
• SiTime Corp (NASDAQ: SITM) in connection with M&A and strategic transactions, including the acquisition of Renesas’ timing business
• Reliance Industries (NSE: Reliance) in several M&A transactions, strategic investments and joint ventures, including its AI joint venture with Meta
• Freshworks (NASDAQ: FRSH) in several M&A transactions
• ChrysCapital in several M&A and strategic transactions
• BPEA EQT and its platform company Sagility Health in several M&A and strategic transactions
• Cytek Biosciences (NASDAQ: CTKB) in connection with M&A and strategic transactions
• Rubrik (NASDAQ: RBRK) in connection with several M&A transactions

Representative sell-side transactions

• The Boston Celtics and the Grousbeck family in connection with the sale of the Celtics to an investor group led by William Chisholm
• Qualified.com in its sale to Salesforce (NYSE: CRM)
• Confluent (NASDAQ: CLFT) in its sale to IBM (NYSE: IBM)
• Datastax in its sale to IBM (NYSE: IBM) 
• Horizon Therapeutics (NASDAQ: HZNP) in its sale to Amgen (NASDAQ: AMGN)
• Absolute Software (NASDAQ: ABST) in its sale to Crosspoint Capital
• NeoPhotonics (NYSE: NPTN) in its sale to Lumentum (NASDAQ: LITE)
• Tilray (NASDAQ: TLRY) in its merger of equals combination with Aphria
• TiVo (NASDAQ: TIVO) in its merger of equals combination with Xperi (NASDAQ: XPER)
• Mindbody (NASDAQ: MB) in its sale to Vista Equity Partners

Representative emerging companies/venture capital transactions

• Peak XV, General Catalyst, Owl Ventures, Lightspeed India Partners and Blume Ventures on investment transactions and M&A
• Airbound, Mstack, Leap Scholar, Seclore, Searce, Pharma Solutions, Alteon Energy and Eos Cyber in connection with private financings, investments and M&A

Rishab is a member of the American Bar Association and is an issue group leader for the ABA’s Private Target Mergers & Acquisitions Deal Points Study.

Rishab is fluent in Hindi, Marathi and Gujarati.